Okay, let's tackle this question. The user is asking about radioimmunoassay results. So, first, I need to recall what a radioimmunoassay (RIA) is. RIA is a technique used to measure the concentration of antigens, like hormones, in a sample. It works by using a known amount of radioactive antigen and a specific antibody. The sample's antigen competes with the radioactive antigen for binding to the antibody.

The question states that the amount of radioactive hormone bound to the antibody is low. In RIA, if there's a lot of the non-radioactive hormone in the sample, it will outcompete the radioactive one for binding to the antibody. So, if the bound radioactive hormone is low, that means there's a high concentration of the hormone in the sample. Because more of the sample's hormone is present, less of the radioactive one binds.

Wait, let me double-check. When there's more antigen in the sample, the antibody has more non-radioactive antigen to bind, so the radioactive antigen (which is added in a fixed amount) has less to bind. So high sample antigen leads to low bound radioactive. Therefore, low bound means high concentration in the sample. So the correct answer would indicate that the patient's hormone level is high.

Now, looking at the options (even though they're not listed here), the correct answer would be something like "High concentration of the hormone in the sample." The other options might suggest low hormone levels, incorrect antibody-antigen interaction, or other factors. For example, if someone thought that low bound radioactivity means low hormone, that's incorrect. Or maybe options about non-specific binding or antibody malfunction.

The clinical pearl here is that RIA is a competitive assay. The more antigen present, the less radioactive antigen binds. Students often confuse this with non-competitive assays like ELISA, where the signal increases with antigen concentration. So it's crucial to remember that RIA is competitive, hence inverse relationship between sample antigen and bound radioactivity.

**Core Concept**
Radioimmunoassay (RIA) is a **competitive binding assay** where a known amount of **radioactive antigen** and **specific antibody** are used. The hormone concentration in a sample inversely correlates with the amount of radioactive antigen bound to the antibody due to competitive inhibition.

**Why the Correct Answer is Right**
In RIA, the sample’s non-radioactive hormone competes with a fixed amount of radioactive hormone for binding to a limited number of antibody sites. **Low bound radioactive hormone** indicates **high endogenous hormone levels** in the sample. This occurs because excess non-radioactive hormone displaces the radioactive tracer from the antibody, reducing its binding. The assay quantifies this inverse relationship to determine the hormone concentration.

**Why Each Wrong Option is Incorrect**
**Option A:** Suggests "Low hormone concentration" — incorrect because low binding implies high, not low, hormone levels.
**Option B:** Implies "Non-specific antibody binding" — irrelevant; RIA relies on specific antibody-antigen interactions.
**Option C:** Claims "Antibody malfunction" — the question states the assay was "properly conducted," ruling out technical failure.

**Clinical Pearl / High-Yield Fact**
RIA is a **competitive assay**, so **higher antigen = lower radioactive signal**. Contrast this with non-competitive assays (e.g.,

✓ Correct Answer: A. Plasma levels of endogenous hormone are high